

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 6.10283789 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 5.85177807 |
| 3 | carnitine shuttle (GO:0006853) | 5.34023862 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 5.32934924 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.31556024 |
| 6 | fatty acid transmembrane transport (GO:1902001) | 5.21724366 |
| 7 | NADH metabolic process (GO:0006734) | 5.13150949 |
| 8 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.10682606 |
| 9 | cellular glucuronidation (GO:0052695) | 5.09031596 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 5.02112514 |
| 11 | uronic acid metabolic process (GO:0006063) | 4.91802783 |
| 12 | glucuronate metabolic process (GO:0019585) | 4.91802783 |
| 13 | triglyceride biosynthetic process (GO:0019432) | 4.91311885 |
| 14 | brown fat cell differentiation (GO:0050873) | 4.90025958 |
| 15 | biotin metabolic process (GO:0006768) | 4.87994993 |
| 16 | regulation of bile acid biosynthetic process (GO:0070857) | 4.83836628 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.77537169 |
| 18 | neutral lipid biosynthetic process (GO:0046460) | 4.72959359 |
| 19 | acylglycerol biosynthetic process (GO:0046463) | 4.72959359 |
| 20 | intestinal absorption (GO:0050892) | 4.67895999 |
| 21 | white fat cell differentiation (GO:0050872) | 4.61044194 |
| 22 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.52589153 |
| 23 | regulation of guanylate cyclase activity (GO:0031282) | 4.50285591 |
| 24 | carnitine transmembrane transport (GO:1902603) | 4.38193407 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 4.37022536 |
| 26 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.36678336 |
| 27 | bile acid and bile salt transport (GO:0015721) | 4.34515018 |
| 28 | triglyceride catabolic process (GO:0019433) | 4.33892866 |
| 29 | fatty acid catabolic process (GO:0009062) | 4.33838915 |
| 30 | acyl-CoA biosynthetic process (GO:0071616) | 4.29896033 |
| 31 | thioester biosynthetic process (GO:0035384) | 4.29896033 |
| 32 | vitamin transmembrane transport (GO:0035461) | 4.28336748 |
| 33 | fatty acid oxidation (GO:0019395) | 4.23503626 |
| 34 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.22739851 |
| 35 | ethanol oxidation (GO:0006069) | 4.21077870 |
| 36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.20708238 |
| 37 | lipid oxidation (GO:0034440) | 4.20077405 |
| 38 | carnitine transport (GO:0015879) | 4.16173426 |
| 39 | amino-acid betaine transport (GO:0015838) | 4.16173426 |
| 40 | positive regulation of fatty acid oxidation (GO:0046321) | 4.11386257 |
| 41 | drug metabolic process (GO:0017144) | 4.07890517 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.05609519 |
| 43 | exogenous drug catabolic process (GO:0042738) | 4.03554196 |
| 44 | glycerol metabolic process (GO:0006071) | 4.03423174 |
| 45 | negative regulation of protein autophosphorylation (GO:0031953) | 4.00225800 |
| 46 | regulation of fatty acid oxidation (GO:0046320) | 3.97559971 |
| 47 | plasma lipoprotein particle assembly (GO:0034377) | 3.97502711 |
| 48 | lipid storage (GO:0019915) | 3.97426530 |
| 49 | drug catabolic process (GO:0042737) | 3.91168856 |
| 50 | valine metabolic process (GO:0006573) | 3.89221467 |
| 51 | ethanol metabolic process (GO:0006067) | 3.89071090 |
| 52 | lipid particle organization (GO:0034389) | 3.87322365 |
| 53 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.85736278 |
| 54 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.82285717 |
| 55 | neutral lipid catabolic process (GO:0046461) | 3.79177964 |
| 56 | acylglycerol catabolic process (GO:0046464) | 3.79177964 |
| 57 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.75110017 |
| 58 | sulfate transmembrane transport (GO:1902358) | 3.73664072 |
| 59 | positive regulation of lipid catabolic process (GO:0050996) | 3.72464176 |
| 60 | high-density lipoprotein particle remodeling (GO:0034375) | 3.71266731 |
| 61 | regulation of cholesterol storage (GO:0010885) | 3.71096362 |
| 62 | transcytosis (GO:0045056) | 3.70404303 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.66919939 |
| 64 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61205235 |
| 65 | proline transport (GO:0015824) | 3.59821530 |
| 66 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.59339018 |
| 67 | endocrine process (GO:0050886) | 3.59339018 |
| 68 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.59339018 |
| 69 | bile acid metabolic process (GO:0008206) | 3.57373888 |
| 70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.57285439 |
| 71 | protein-lipid complex remodeling (GO:0034368) | 3.57285439 |
| 72 | macromolecular complex remodeling (GO:0034367) | 3.57285439 |
| 73 | angiotensin maturation (GO:0002003) | 3.56598658 |
| 74 | alditol metabolic process (GO:0019400) | 3.56568600 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 3.56557275 |
| 76 | arginine metabolic process (GO:0006525) | 3.54736900 |
| 77 | drug transmembrane transport (GO:0006855) | 3.54344527 |
| 78 | diacylglycerol metabolic process (GO:0046339) | 3.53988420 |
| 79 | primary alcohol catabolic process (GO:0034310) | 3.51035328 |
| 80 | hemidesmosome assembly (GO:0031581) | 3.49616509 |
| 81 | lipoprotein transport (GO:0042953) | 3.49266289 |
| 82 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.47928043 |
| 83 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.46052177 |
| 84 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.46052177 |
| 85 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.46034990 |
| 86 | phospholipid efflux (GO:0033700) | 3.44587928 |
| 87 | reverse cholesterol transport (GO:0043691) | 3.43864157 |
| 88 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.42296047 |
| 89 | protein-lipid complex assembly (GO:0065005) | 3.41252271 |
| 90 | phenylpropanoid metabolic process (GO:0009698) | 3.40533788 |
| 91 | intracellular lipid transport (GO:0032365) | 3.39729948 |
| 92 | desmosome organization (GO:0002934) | 3.38966439 |
| 93 | cholesterol efflux (GO:0033344) | 3.38853565 |
| 94 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.37897052 |
| 95 | adenosine metabolic process (GO:0046085) | 3.34883473 |
| 96 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.33778807 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 3.32593654 |
| 98 | alanine transport (GO:0032328) | 3.32460213 |
| 99 | triglyceride metabolic process (GO:0006641) | 3.31015096 |
| 100 | drug transport (GO:0015893) | 3.30302156 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.27799061 |
| 102 | coenzyme A biosynthetic process (GO:0015937) | 3.27617295 |
| 103 | long-chain fatty acid transport (GO:0015909) | 3.26256143 |
| 104 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.24632887 |
| 105 | sphingomyelin metabolic process (GO:0006684) | 3.22762556 |
| 106 | hormone catabolic process (GO:0042447) | 3.21910571 |
| 107 | monocarboxylic acid catabolic process (GO:0072329) | 3.20164771 |
| 108 | regulation of protein activation cascade (GO:2000257) | 3.19557717 |
| 109 | intestinal cholesterol absorption (GO:0030299) | 3.18312725 |
| 110 | peptide hormone processing (GO:0016486) | 3.17792638 |
| 111 | lipoprotein metabolic process (GO:0042157) | 3.17305176 |
| 112 | regulation of systemic arterial blood pressure (GO:0003073) | 3.16008284 |
| 113 | primary alcohol metabolic process (GO:0034308) | 3.15770223 |
| 114 | regulation of complement activation (GO:0030449) | 3.14828284 |
| 115 | acylglycerol metabolic process (GO:0006639) | 3.13994847 |
| 116 | acyl-CoA metabolic process (GO:0006637) | 3.13264306 |
| 117 | thioester metabolic process (GO:0035383) | 3.13264306 |
| 118 | actin filament depolymerization (GO:0030042) | 3.12537891 |
| 119 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11881446 |
| 120 | O-glycan processing (GO:0016266) | 3.10705695 |
| 121 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.10539570 |
| 122 | neutral lipid metabolic process (GO:0006638) | 3.08516187 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.08400024 |
| 124 | quaternary ammonium group transport (GO:0015697) | 3.07959596 |
| 125 | cGMP-mediated signaling (GO:0019934) | 3.07554824 |
| 126 | urea metabolic process (GO:0019627) | 3.07358857 |
| 127 | digestion (GO:0007586) | 3.05872463 |
| 128 | protein-lipid complex subunit organization (GO:0071825) | 3.05845478 |
| 129 | vitamin transport (GO:0051180) | 3.05795691 |
| 130 | NADPH regeneration (GO:0006740) | 3.04892009 |
| 131 | urea cycle (GO:0000050) | 3.04475570 |
| 132 | heme transport (GO:0015886) | 3.03963831 |
| 133 | sulfate transport (GO:0008272) | 3.03327630 |
| 134 | sterol homeostasis (GO:0055092) | 3.02837431 |
| 135 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.02484517 |
| 136 | branched-chain amino acid catabolic process (GO:0009083) | 3.02362629 |
| 137 | transepithelial transport (GO:0070633) | 3.01912323 |
| 138 | succinate metabolic process (GO:0006105) | 3.00274218 |
| 139 | negative regulation of protein activation cascade (GO:2000258) | 2.99581757 |
| 140 | L-ascorbic acid metabolic process (GO:0019852) | 2.99329368 |
| 141 | L-serine transport (GO:0015825) | 2.95466612 |
| 142 | pentose-phosphate shunt (GO:0006098) | 2.94514204 |
| 143 | protein carboxylation (GO:0018214) | 2.93729303 |
| 144 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93729303 |
| 145 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.92481075 |
| 146 | branched-chain amino acid metabolic process (GO:0009081) | 2.92341360 |
| 147 | tricarboxylic acid metabolic process (GO:0072350) | 2.91948620 |
| 148 | glycerolipid catabolic process (GO:0046503) | 2.91357981 |
| 149 | urate metabolic process (GO:0046415) | 2.90600999 |
| 150 | intestinal epithelial cell development (GO:0060576) | 2.90495476 |
| 151 | response to dietary excess (GO:0002021) | 2.89462629 |
| 152 | retinol metabolic process (GO:0042572) | 2.88582726 |
| 153 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.88566629 |
| 154 | alkaloid metabolic process (GO:0009820) | 2.88161747 |
| 155 | glycine transport (GO:0015816) | 2.88133915 |
| 156 | flavonoid metabolic process (GO:0009812) | 2.88014584 |
| 157 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.87838491 |
| 158 | digestive system process (GO:0022600) | 2.87600518 |
| 159 | regulation of cholesterol metabolic process (GO:0090181) | 2.87078060 |
| 160 | fructose metabolic process (GO:0006000) | 2.86146989 |
| 161 | negative regulation of complement activation (GO:0045916) | 2.85240282 |
| 162 | fatty acid transport (GO:0015908) | 2.85087282 |
| 163 | cellular response to lithium ion (GO:0071285) | 2.84777797 |
| 164 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.84376769 |
| 165 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.83023878 |
| 166 | auditory receptor cell differentiation (GO:0042491) | 2.82553677 |
| 167 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82295703 |
| 168 | L-phenylalanine metabolic process (GO:0006558) | 2.82295703 |
| 169 | sulfur compound transport (GO:0072348) | 2.82039262 |
| 170 | sodium ion homeostasis (GO:0055078) | 2.80797057 |
| 171 | alpha-linolenic acid metabolic process (GO:0036109) | 2.79977789 |
| 172 | amino acid transmembrane transport (GO:0003333) | 2.77870182 |
| 173 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77823965 |
| 174 | L-phenylalanine catabolic process (GO:0006559) | 2.77823965 |
| 175 | positive regulation of lipid storage (GO:0010884) | 2.77698180 |
| 176 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.76241368 |
| 177 | complement activation, classical pathway (GO:0006958) | 2.73573533 |
| 178 | nitrogen cycle metabolic process (GO:0071941) | 2.73176733 |
| 179 | carnitine metabolic process (GO:0009437) | 2.72933951 |
| 180 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.72876174 |
| 181 | short-chain fatty acid metabolic process (GO:0046459) | 2.71982966 |
| 182 | cellular lipid catabolic process (GO:0044242) | 2.64791203 |
| 183 | regulation of cholesterol transport (GO:0032374) | 2.64268776 |
| 184 | regulation of sterol transport (GO:0032371) | 2.64268776 |
| 185 | regulation of triglyceride metabolic process (GO:0090207) | 2.62966568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.78966346 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.18271708 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.08974788 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87856031 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.66090341 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.44620862 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.41126756 |
| 8 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.36755858 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.32166330 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29341613 |
| 11 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.26292807 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22017436 |
| 13 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.12976032 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.12122678 |
| 15 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.11786970 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06141227 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02805162 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00345569 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.3692154 |
| 20 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.99372468 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90132797 |
| 22 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.78793966 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.76103379 |
| 24 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71612734 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66588625 |
| 26 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.66456265 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61420350 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58632523 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.55155469 |
| 30 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.53746972 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53323002 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50552505 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49331297 |
| 34 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.48020780 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.44151849 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43952662 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43234884 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.39192498 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38667944 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36923568 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.28476112 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27259474 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26488808 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25798823 |
| 45 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23493122 |
| 46 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19946748 |
| 47 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.18907042 |
| 48 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17369677 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16617213 |
| 50 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 1.15881206 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15309361 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14692021 |
| 53 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.14628098 |
| 54 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14502866 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14442784 |
| 56 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.13495544 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12235767 |
| 58 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.10610894 |
| 59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10585888 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10575038 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10346751 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09849387 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09445174 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07799099 |
| 65 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06761330 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05389836 |
| 67 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05195456 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04981315 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04096107 |
| 70 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.03362004 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03357631 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02619981 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99578615 |
| 74 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99482162 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99144675 |
| 76 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98589382 |
| 77 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98589382 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98559549 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98015898 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97671462 |
| 81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97140199 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95650215 |
| 83 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95292511 |
| 84 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95292511 |
| 85 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95063024 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95050853 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94852506 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93771398 |
| 89 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.93564217 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93159075 |
| 91 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92620117 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91623973 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91379863 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91323432 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90065261 |
| 96 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89254020 |
| 97 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88853195 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88502423 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84999652 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84518868 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84512942 |
| 102 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84453745 |
| 103 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.83965364 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83382963 |
| 105 | NCOR_22424771_ChIP-Seq_293T_Human | 0.82891380 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81432842 |
| 107 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80765566 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79812814 |
| 109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79737050 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79654918 |
| 111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79608799 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79568887 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79214612 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79070486 |
| 115 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.79024668 |
| 116 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78928762 |
| 117 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78811560 |
| 118 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78804010 |
| 119 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.77620265 |
| 120 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76802081 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.76551863 |
| 122 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.76502342 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76133313 |
| 124 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.76088384 |
| 125 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.75647384 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74927035 |
| 127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74596645 |
| 128 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.74155057 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73202034 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73130761 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72920162 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72920162 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72782535 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72246093 |
| 135 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71638442 |
| 136 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.71537301 |
| 137 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.70856781 |
| 138 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.70032905 |
| 139 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.69421752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.01086569 |
| 2 | MP0005666_abnormal_adipose_tissue | 4.23933859 |
| 3 | MP0004185_abnormal_adipocyte_glucose | 3.62097306 |
| 4 | MP0004130_abnormal_muscle_cell | 3.40174719 |
| 5 | MP0005360_urolithiasis | 3.38058584 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.36321526 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.10900229 |
| 8 | MP0005375_adipose_tissue_phenotype | 2.81585515 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.80344278 |
| 10 | MP0002971_abnormal_brown_adipose | 2.67722400 |
| 11 | MP0003195_calcinosis | 2.61744614 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.50574047 |
| 13 | MP0002736_abnormal_nociception_after | 2.43361101 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.32525613 |
| 15 | MP0009115_abnormal_fat_cell | 2.22340394 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.21630610 |
| 17 | MP0003866_abnormal_defecation | 2.15938305 |
| 18 | MP0000013_abnormal_adipose_tissue | 2.12749336 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.12338367 |
| 20 | MP0003868_abnormal_feces_composition | 2.06150614 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.03779134 |
| 22 | MP0001986_abnormal_taste_sensitivity | 2.02659104 |
| 23 | MP0004264_abnormal_extraembryonic_tissu | 1.94135084 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 1.92820965 |
| 25 | MP0005334_abnormal_fat_pad | 1.87918531 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.85005862 |
| 27 | MP0000003_abnormal_adipose_tissue | 1.77049086 |
| 28 | MP0002796_impaired_skin_barrier | 1.74179236 |
| 29 | MP0005448_abnormal_energy_balance | 1.71535762 |
| 30 | MP0000566_synostosis | 1.69200242 |
| 31 | MP0005535_abnormal_body_temperature | 1.67227767 |
| 32 | MP0002970_abnormal_white_adipose | 1.64009880 |
| 33 | MP0004147_increased_porphyrin_level | 1.58498695 |
| 34 | MP0000462_abnormal_digestive_system | 1.56221184 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.55327926 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.53158761 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.53096457 |
| 38 | MP0005275_abnormal_skin_tensile | 1.52009620 |
| 39 | MP0005365_abnormal_bile_salt | 1.50373379 |
| 40 | MP0001664_abnormal_digestion | 1.48293760 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.47531181 |
| 42 | MP0001663_abnormal_digestive_system | 1.47471071 |
| 43 | MP0008438_abnormal_cutaneous_collagen | 1.42268492 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.38478788 |
| 45 | MP0005409_darkened_coat_color | 1.34803168 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.34075099 |
| 47 | MP0001756_abnormal_urination | 1.32496884 |
| 48 | MP0003879_abnormal_hair_cell | 1.31765348 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.31076516 |
| 50 | MP0003724_increased_susceptibility_to | 1.30865157 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.30685755 |
| 52 | MP0010678_abnormal_skin_adnexa | 1.30479276 |
| 53 | MP0005381_digestive/alimentary_phenotyp | 1.28688195 |
| 54 | MP0004858_abnormal_nervous_system | 1.26036598 |
| 55 | MP0000538_abnormal_urinary_bladder | 1.25974233 |
| 56 | MP0000609_abnormal_liver_physiology | 1.25948931 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.25456792 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.23516541 |
| 59 | MP0009840_abnormal_foam_cell | 1.23357469 |
| 60 | MP0005332_abnormal_amino_acid | 1.22328848 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 1.18760425 |
| 62 | MP0003045_fibrosis | 1.17152700 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14266561 |
| 64 | MP0008872_abnormal_physiological_respon | 1.11761759 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.10763243 |
| 66 | MP0002254_reproductive_system_inflammat | 1.10715554 |
| 67 | MP0001970_abnormal_pain_threshold | 1.10423854 |
| 68 | MP0008004_abnormal_stomach_pH | 1.08571952 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.08339474 |
| 70 | MP0000537_abnormal_urethra_morphology | 1.08058733 |
| 71 | MP0001661_extended_life_span | 1.07659751 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.07176234 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.06964607 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.06754917 |
| 75 | MP0001873_stomach_inflammation | 1.05146856 |
| 76 | MP0004270_analgesia | 1.05038314 |
| 77 | MP0003959_abnormal_lean_body | 1.03819944 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.02491073 |
| 79 | MP0009379_abnormal_foot_pigmentation | 1.02042936 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.01427148 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 1.01392781 |
| 82 | MP0000477_abnormal_intestine_morphology | 0.96321236 |
| 83 | MP0005083_abnormal_biliary_tract | 0.94913055 |
| 84 | MP0002060_abnormal_skin_morphology | 0.94657654 |
| 85 | MP0010771_integument_phenotype | 0.93701589 |
| 86 | MP0005452_abnormal_adipose_tissue | 0.92096424 |
| 87 | MP0003011_delayed_dark_adaptation | 0.91900941 |
| 88 | MP0000427_abnormal_hair_cycle | 0.91800089 |
| 89 | MP0003186_abnormal_redox_activity | 0.90308935 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.88503415 |
| 91 | MP0004043_abnormal_pH_regulation | 0.88211044 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.87977478 |
| 93 | MP0005408_hypopigmentation | 0.83660262 |
| 94 | MP0002006_tumorigenesis | 0.82734097 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.82078337 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.80906590 |
| 97 | MP0001881_abnormal_mammary_gland | 0.80494463 |
| 98 | MP0005501_abnormal_skin_physiology | 0.80242238 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.80000562 |
| 100 | MP0001764_abnormal_homeostasis | 0.79056954 |
| 101 | MP0003252_abnormal_bile_duct | 0.78857689 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.78452701 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.76656878 |
| 104 | MP0004272_abnormal_basement_membrane | 0.76612485 |
| 105 | MP0002132_abnormal_respiratory_system | 0.75942537 |
| 106 | MP0005166_decreased_susceptibility_to | 0.75825252 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.75728960 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75004407 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.74997409 |
| 110 | MP0002009_preneoplasia | 0.74507907 |
| 111 | MP0004484_altered_response_of | 0.74257506 |
| 112 | MP0003878_abnormal_ear_physiology | 0.73958224 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.73958224 |
| 114 | MP0006276_abnormal_autonomic_nervous | 0.73128144 |
| 115 | MP0003953_abnormal_hormone_level | 0.73051199 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.71944374 |
| 117 | MP0009697_abnormal_copulation | 0.71434966 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.68918369 |
| 119 | MP0003718_maternal_effect | 0.68289125 |
| 120 | MP0000383_abnormal_hair_follicle | 0.68040712 |
| 121 | MP0010386_abnormal_urinary_bladder | 0.67640393 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.65958816 |
| 123 | MP0003122_maternal_imprinting | 0.63846679 |
| 124 | MP0008469_abnormal_protein_level | 0.62701530 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.61672856 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.61027410 |
| 127 | MP0005058_abnormal_lysosome_morphology | 0.60008133 |
| 128 | MP0000490_abnormal_crypts_of | 0.57517224 |
| 129 | MP0005367_renal/urinary_system_phenotyp | 0.56545065 |
| 130 | MP0000516_abnormal_urinary_system | 0.56545065 |
| 131 | MP0005310_abnormal_salivary_gland | 0.55880397 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.55164351 |
| 133 | MP0001944_abnormal_pancreas_morphology | 0.54680558 |
| 134 | MP0000604_amyloidosis | 0.54140073 |
| 135 | MP0005395_other_phenotype | 0.51893923 |
| 136 | MP0001845_abnormal_inflammatory_respons | 0.51666638 |
| 137 | MP0005379_endocrine/exocrine_gland_phen | 0.51172032 |
| 138 | MP0003329_amyloid_beta_deposits | 0.50707121 |
| 139 | MP0000467_abnormal_esophagus_morphology | 0.48422138 |
| 140 | MP0005645_abnormal_hypothalamus_physiol | 0.48061628 |
| 141 | MP0005220_abnormal_exocrine_pancreas | 0.47223715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 5.52923114 |
| 2 | Hyperglycinuria (HP:0003108) | 5.47698634 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.11505817 |
| 4 | Ileus (HP:0002595) | 5.04809072 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 5.01270049 |
| 6 | Hydroxyprolinuria (HP:0003080) | 5.01270049 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.40236628 |
| 8 | Acanthosis nigricans (HP:0000956) | 4.23798625 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.23325261 |
| 10 | Fat malabsorption (HP:0002630) | 4.19924092 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16908387 |
| 12 | Decreased circulating renin level (HP:0003351) | 4.15164290 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.07288502 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07288502 |
| 15 | Myoglobinuria (HP:0002913) | 4.05581133 |
| 16 | Deep venous thrombosis (HP:0002625) | 4.01293491 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.96648918 |
| 18 | Acanthocytosis (HP:0001927) | 3.87388339 |
| 19 | Xanthomatosis (HP:0000991) | 3.83921950 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.79619397 |
| 21 | Dicarboxylic aciduria (HP:0003215) | 3.63460944 |
| 22 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.63460944 |
| 23 | Hypertriglyceridemia (HP:0002155) | 3.61846489 |
| 24 | Increased muscle lipid content (HP:0009058) | 3.61418541 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 3.54192041 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.52300354 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.50139151 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.47673694 |
| 29 | Palpitations (HP:0001962) | 3.41464939 |
| 30 | Vascular calcification (HP:0004934) | 3.38405512 |
| 31 | Abnormality of vitamin metabolism (HP:0100508) | 3.27814822 |
| 32 | Hepatic necrosis (HP:0002605) | 3.26811151 |
| 33 | Alkalosis (HP:0001948) | 3.24689609 |
| 34 | Nausea (HP:0002018) | 3.22674157 |
| 35 | Bone cyst (HP:0012062) | 3.22646847 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 3.17378291 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17346571 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 3.08170862 |
| 39 | Pigmentary retinal degeneration (HP:0001146) | 3.04680688 |
| 40 | Widely patent fontanelles and sutures (HP:0004492) | 3.01863551 |
| 41 | Hyperammonemia (HP:0001987) | 3.01836969 |
| 42 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.01669098 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98761357 |
| 44 | Pheochromocytoma (HP:0002666) | 2.93280388 |
| 45 | Glomerulonephritis (HP:0000099) | 2.92225362 |
| 46 | Epidermoid cyst (HP:0200040) | 2.90779409 |
| 47 | Malnutrition (HP:0004395) | 2.87786157 |
| 48 | Complement deficiency (HP:0004431) | 2.86193026 |
| 49 | Facial diplegia (HP:0001349) | 2.85554732 |
| 50 | Chronic diarrhea (HP:0002028) | 2.83647444 |
| 51 | Long foot (HP:0001833) | 2.79833673 |
| 52 | Growth hormone excess (HP:0000845) | 2.79280476 |
| 53 | Cardiovascular calcification (HP:0011915) | 2.78318968 |
| 54 | Ketoacidosis (HP:0001993) | 2.72023873 |
| 55 | Goiter (HP:0000853) | 2.71627498 |
| 56 | Conjunctival hamartoma (HP:0100780) | 2.69541192 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.67552017 |
| 58 | Steatorrhea (HP:0002570) | 2.65100013 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.65003751 |
| 60 | Congenital sensorineural hearing impairment (HP:0008527) | 2.63888087 |
| 61 | Hyperaldosteronism (HP:0000859) | 2.63751665 |
| 62 | Abnormal tarsal ossification (HP:0008369) | 2.59899046 |
| 63 | Neuroendocrine neoplasm (HP:0100634) | 2.53908292 |
| 64 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.53466289 |
| 65 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.53466289 |
| 66 | Joint hemorrhage (HP:0005261) | 2.51640275 |
| 67 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.50296912 |
| 68 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.50133873 |
| 69 | Absent/shortened dynein arms (HP:0200106) | 2.50133873 |
| 70 | Pancreatitis (HP:0001733) | 2.48967151 |
| 71 | Muscle stiffness (HP:0003552) | 2.48558936 |
| 72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.48437276 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.47155185 |
| 74 | Insulin resistance (HP:0000855) | 2.43266255 |
| 75 | Potter facies (HP:0002009) | 2.39123510 |
| 76 | Facial shape deformation (HP:0011334) | 2.39123510 |
| 77 | Chronic bronchitis (HP:0004469) | 2.38843674 |
| 78 | Mesangial abnormality (HP:0001966) | 2.38795615 |
| 79 | Abdominal distention (HP:0003270) | 2.37920511 |
| 80 | Abnormal ciliary motility (HP:0012262) | 2.31735706 |
| 81 | Hepatocellular necrosis (HP:0001404) | 2.30975349 |
| 82 | Confusion (HP:0001289) | 2.26793890 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.25307822 |
| 84 | Gastrointestinal dysmotility (HP:0002579) | 2.24887280 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 2.24877352 |
| 86 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.23582799 |
| 87 | Hypercortisolism (HP:0001578) | 2.22881352 |
| 88 | Increased connective tissue (HP:0009025) | 2.22645305 |
| 89 | Rickets (HP:0002748) | 2.22138057 |
| 90 | Hypotension (HP:0002615) | 2.20860355 |
| 91 | Ketosis (HP:0001946) | 2.20569850 |
| 92 | Difficulty running (HP:0009046) | 2.20061539 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 2.18109004 |
| 94 | Abnormality of the vocal cords (HP:0008777) | 2.17822118 |
| 95 | Abnormal hemoglobin (HP:0011902) | 2.17699128 |
| 96 | Dehydration (HP:0001944) | 2.16838963 |
| 97 | Onycholysis (HP:0001806) | 2.15935493 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14637047 |
| 99 | Lethargy (HP:0001254) | 2.14523990 |
| 100 | Abnormality of urine glucose concentration (HP:0011016) | 2.13126858 |
| 101 | Glycosuria (HP:0003076) | 2.13126858 |
| 102 | Abnormality of complement system (HP:0005339) | 2.13087165 |
| 103 | Villous atrophy (HP:0011473) | 2.12373150 |
| 104 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.12373150 |
| 105 | Metabolic alkalosis (HP:0200114) | 2.11015255 |
| 106 | Acute encephalopathy (HP:0006846) | 2.09372070 |
| 107 | Flat acetabular roof (HP:0003180) | 2.09011741 |
| 108 | Nephritis (HP:0000123) | 2.08119337 |
| 109 | Abnormality of the common coagulation pathway (HP:0010990) | 2.07349983 |
| 110 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07139150 |
| 111 | Hemorrhage of the eye (HP:0011885) | 2.06645199 |
| 112 | Gout (HP:0001997) | 2.06403728 |
| 113 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.06008819 |
| 114 | Cerebral hemorrhage (HP:0001342) | 2.04811161 |
| 115 | Rhinitis (HP:0012384) | 2.04558106 |
| 116 | Hypokalemia (HP:0002900) | 2.03398593 |
| 117 | Ventricular fibrillation (HP:0001663) | 2.03342779 |
| 118 | Hyperkalemia (HP:0002153) | 2.03321007 |
| 119 | Increased serum pyruvate (HP:0003542) | 2.02813542 |
| 120 | Abnormality of glycolysis (HP:0004366) | 2.02813542 |
| 121 | Insidious onset (HP:0003587) | 2.02681679 |
| 122 | Termporal pattern (HP:0011008) | 2.02681679 |
| 123 | Hyperphosphaturia (HP:0003109) | 2.01438892 |
| 124 | Bronchiectasis (HP:0002110) | 2.00411862 |
| 125 | Atrophic scars (HP:0001075) | 1.99734370 |
| 126 | Vomiting (HP:0002013) | 1.98762128 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.98717991 |
| 128 | Tetraparesis (HP:0002273) | 1.98640725 |
| 129 | Hypoalphalipoproteinemia (HP:0003233) | 1.98586363 |
| 130 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98079925 |
| 131 | Autoimmune hemolytic anemia (HP:0001890) | 1.96858510 |
| 132 | Abnormal glucose tolerance (HP:0001952) | 1.95903106 |
| 133 | Abnormal urine phosphate concentration (HP:0012599) | 1.95597011 |
| 134 | Abnormality of potassium homeostasis (HP:0011042) | 1.94830494 |
| 135 | Bradycardia (HP:0001662) | 1.94609669 |
| 136 | Methylmalonic aciduria (HP:0012120) | 1.94571993 |
| 137 | Multiple enchondromatosis (HP:0005701) | 1.92815911 |
| 138 | Palmoplantar hyperkeratosis (HP:0000972) | 1.91295203 |
| 139 | Glomerulosclerosis (HP:0000096) | 1.89908371 |
| 140 | Abnormality of purine metabolism (HP:0004352) | 1.89835980 |
| 141 | Lactic acidosis (HP:0003128) | 1.88979773 |
| 142 | Conjugated hyperbilirubinemia (HP:0002908) | 1.88610921 |
| 143 | Abnormality of chloride homeostasis (HP:0011422) | 1.88456563 |
| 144 | Hyperglycinemia (HP:0002154) | 1.88328043 |
| 145 | Abnormal biliary tract morphology (HP:0012440) | 1.88324932 |
| 146 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88292443 |
| 147 | Metabolic acidosis (HP:0001942) | 1.87493141 |
| 148 | Protuberant abdomen (HP:0001538) | 1.86948774 |
| 149 | Pili torti (HP:0003777) | 1.86077948 |
| 150 | Hyperparathyroidism (HP:0000843) | 1.85849901 |
| 151 | Hyperlipoproteinemia (HP:0010980) | 1.84992644 |
| 152 | Hypophosphatemia (HP:0002148) | 1.84811697 |
| 153 | Mucopolysacchariduria (HP:0008155) | 1.84309156 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84309156 |
| 155 | Cupped ribs (HP:0000887) | 1.83780821 |
| 156 | Abnormality of vitamin B metabolism (HP:0004340) | 1.83724453 |
| 157 | Abnormal hair laboratory examination (HP:0003328) | 1.81521394 |
| 158 | Hyponatremia (HP:0002902) | 1.80676527 |
| 159 | Abnormality of magnesium homeostasis (HP:0004921) | 1.79950915 |
| 160 | Rectal prolapse (HP:0002035) | 1.78637135 |
| 161 | Curly hair (HP:0002212) | 1.78507741 |
| 162 | Hypothermia (HP:0002045) | 1.77111231 |
| 163 | Hyperuricemia (HP:0002149) | 1.77096360 |
| 164 | Increased purine levels (HP:0004368) | 1.77096360 |
| 165 | Hypercholesterolemia (HP:0003124) | 1.76932565 |
| 166 | Myotonia (HP:0002486) | 1.76218073 |
| 167 | Cerebral edema (HP:0002181) | 1.75792063 |
| 168 | Subcapsular cataract (HP:0000523) | 1.75659602 |
| 169 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75519306 |
| 170 | Abnormality of pain sensation (HP:0010832) | 1.75148715 |
| 171 | Impaired pain sensation (HP:0007328) | 1.75148715 |
| 172 | Athetosis (HP:0002305) | 1.74400297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.97389927 |
| 2 | LMTK2 | 4.96964737 |
| 3 | FRK | 4.70179948 |
| 4 | MST1R | 4.63054454 |
| 5 | CAMK1D | 3.21360033 |
| 6 | STK39 | 3.17135669 |
| 7 | PDK4 | 2.99161688 |
| 8 | PDK3 | 2.99161688 |
| 9 | TRIB3 | 2.62669708 |
| 10 | BCKDK | 2.59352476 |
| 11 | MST4 | 2.51198040 |
| 12 | RIPK1 | 2.37331081 |
| 13 | MAP3K2 | 2.30798953 |
| 14 | PRKG2 | 2.25492412 |
| 15 | PDK2 | 2.02131544 |
| 16 | KSR2 | 1.99846091 |
| 17 | OXSR1 | 1.98662756 |
| 18 | MYLK | 1.96898146 |
| 19 | MAP2K1 | 1.91312658 |
| 20 | MAP2K2 | 1.84222947 |
| 21 | EPHB2 | 1.80133129 |
| 22 | CAMK1G | 1.77690567 |
| 23 | STK24 | 1.72244168 |
| 24 | MAPK15 | 1.66728366 |
| 25 | FER | 1.62950256 |
| 26 | RIPK4 | 1.58331964 |
| 27 | MET | 1.56736817 |
| 28 | PIK3CA | 1.55788586 |
| 29 | GRK5 | 1.51351060 |
| 30 | GRK1 | 1.50020680 |
| 31 | PRKAA2 | 1.44670301 |
| 32 | NME1 | 1.42303546 |
| 33 | TESK1 | 1.35903244 |
| 34 | CASK | 1.35672084 |
| 35 | NLK | 1.31456647 |
| 36 | ADRBK2 | 1.23353009 |
| 37 | SIK1 | 1.21300006 |
| 38 | ARAF | 1.18751167 |
| 39 | EPHA2 | 1.11338866 |
| 40 | MAP2K6 | 1.09582858 |
| 41 | FGFR3 | 1.06986124 |
| 42 | EPHA3 | 1.05882710 |
| 43 | MAP3K9 | 1.01411677 |
| 44 | ERN1 | 1.00856674 |
| 45 | LIMK1 | 1.00376375 |
| 46 | MAP3K12 | 0.99818307 |
| 47 | PDPK1 | 0.93542855 |
| 48 | RET | 0.91548530 |
| 49 | MATK | 0.91028134 |
| 50 | PTK6 | 0.88216281 |
| 51 | CDK9 | 0.85272445 |
| 52 | MAPKAPK3 | 0.84538305 |
| 53 | IRAK3 | 0.81086329 |
| 54 | PRKAA1 | 0.80895050 |
| 55 | TAOK1 | 0.80712073 |
| 56 | NEK9 | 0.79897430 |
| 57 | EPHB1 | 0.79760125 |
| 58 | YES1 | 0.75561631 |
| 59 | MAP3K1 | 0.75087983 |
| 60 | STK38 | 0.74992826 |
| 61 | PDK1 | 0.74635853 |
| 62 | IRAK1 | 0.73758854 |
| 63 | TNIK | 0.72782076 |
| 64 | WNK3 | 0.71804585 |
| 65 | BRSK2 | 0.71634591 |
| 66 | CDK6 | 0.69429389 |
| 67 | NTRK1 | 0.68438594 |
| 68 | FGFR4 | 0.67734244 |
| 69 | PRKD3 | 0.64265585 |
| 70 | PIM2 | 0.62757739 |
| 71 | DDR2 | 0.61303188 |
| 72 | INSRR | 0.60277414 |
| 73 | BCR | 0.59764614 |
| 74 | PRKCZ | 0.58509672 |
| 75 | PTK2 | 0.58155624 |
| 76 | PRKACG | 0.56345713 |
| 77 | WNK1 | 0.56213580 |
| 78 | TYK2 | 0.55694883 |
| 79 | MAPK11 | 0.55336928 |
| 80 | BMPR1B | 0.54494892 |
| 81 | STK3 | 0.54337935 |
| 82 | DYRK1B | 0.53759164 |
| 83 | AKT3 | 0.53185322 |
| 84 | JAK1 | 0.51586757 |
| 85 | DAPK2 | 0.51209438 |
| 86 | RPS6KA2 | 0.50152458 |
| 87 | MAP3K3 | 0.49808120 |
| 88 | STK38L | 0.49073295 |
| 89 | PHKG2 | 0.44745615 |
| 90 | PHKG1 | 0.44745615 |
| 91 | CDC42BPA | 0.44108147 |
| 92 | EPHA4 | 0.43952017 |
| 93 | MAP4K2 | 0.43484059 |
| 94 | WNK4 | 0.42938869 |
| 95 | PRKCQ | 0.42573847 |
| 96 | SGK3 | 0.42477492 |
| 97 | JAK2 | 0.40969689 |
| 98 | PAK3 | 0.40922724 |
| 99 | LATS1 | 0.40008007 |
| 100 | ERBB3 | 0.39801903 |
| 101 | SRC | 0.39687763 |
| 102 | PDGFRA | 0.39534161 |
| 103 | TIE1 | 0.39363940 |
| 104 | GRK6 | 0.36627788 |
| 105 | ERBB2 | 0.36272333 |
| 106 | SGK223 | 0.35602581 |
| 107 | SGK494 | 0.35602581 |
| 108 | MARK3 | 0.32668501 |
| 109 | FGFR1 | 0.32561725 |
| 110 | TNK2 | 0.31889595 |
| 111 | LRRK2 | 0.31746212 |
| 112 | GSK3A | 0.31003741 |
| 113 | TRPM7 | 0.29869267 |
| 114 | CAMKK2 | 0.29102039 |
| 115 | FGFR2 | 0.28049516 |
| 116 | PRKCE | 0.27807258 |
| 117 | ITK | 0.27448137 |
| 118 | CAMK2D | 0.27383373 |
| 119 | PRKCI | 0.26484206 |
| 120 | TLK1 | 0.26424933 |
| 121 | IGF1R | 0.26408683 |
| 122 | CSNK1A1 | 0.26214252 |
| 123 | SGK1 | 0.26024000 |
| 124 | SGK2 | 0.25860991 |
| 125 | PINK1 | 0.25403388 |
| 126 | PIK3CG | 0.25316578 |
| 127 | NEK6 | 0.25284447 |
| 128 | ADRBK1 | 0.25091352 |
| 129 | RPS6KB1 | 0.23764487 |
| 130 | EIF2AK1 | 0.23195441 |
| 131 | NUAK1 | 0.22987071 |
| 132 | PRKCA | 0.22306045 |
| 133 | PTK2B | 0.21495397 |
| 134 | PKN2 | 0.20562967 |
| 135 | ILK | 0.20534948 |
| 136 | TBK1 | 0.20440919 |
| 137 | CAMK2G | 0.19764467 |
| 138 | MAPK4 | 0.19628738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.07965134 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.64136887 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.36707020 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.28523437 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.22359371 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11427286 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.10532439 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.90772988 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82573022 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.53406212 |
| 11 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.51083198 |
| 12 | Mineral absorption_Homo sapiens_hsa04978 | 2.46914737 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.37599904 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.25814468 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.19641236 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.17706606 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.16781590 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16396028 |
| 19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.09179778 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.96579152 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.83869852 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74975025 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.72110750 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.70213426 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64943150 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.58068816 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44006582 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43123911 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42582611 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38573613 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31196574 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.30597384 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.29475172 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28878393 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25836399 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25604892 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24890882 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22895746 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17190544 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14186645 |
| 41 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.13771189 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12212372 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.07860734 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07339890 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06255853 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05112120 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02566146 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.99687795 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96525976 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96492572 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95308034 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.94125924 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90032786 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88692627 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83741814 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81323959 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80626509 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78390391 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75577072 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74094887 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73924404 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71538167 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71284056 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70098076 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67830811 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.67777792 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67054641 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65108402 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64930646 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59674717 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57856047 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.55026570 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52792559 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52358669 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51429098 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50833991 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50303373 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.49977419 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46513521 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45644557 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43163229 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42511384 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41055471 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40978924 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40905196 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39811913 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.39629919 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38031014 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36013788 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35010128 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34946510 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33319438 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.33033487 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32687598 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30975375 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.30674487 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30673899 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.30559160 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30344522 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30237181 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29507828 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.28698182 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27963923 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27163754 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27094891 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26194460 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24400807 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.24180389 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23665560 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23425611 |
| 111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23032044 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22459736 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22082670 |
| 114 | Asthma_Homo sapiens_hsa05310 | 0.21883071 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21445863 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.19939641 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18842607 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18824910 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15503963 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15086524 |
| 121 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.15014927 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14362733 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.14158399 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.14020640 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.13030716 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12813405 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.12057138 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06619982 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.06478808 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.06182331 |

